Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL(PRO) and 3CL(PRO) proteases

The pandemic, COVID-19, has spread worldwide and affected millions of people. There is an urgent need, therefore, to find a proper treatment for the novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative agent. This paper focuses on identifying inhibitors that...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur J Pharmacol
Egile Nagusiak: Jade, Dhananjay, Ayyamperumal, Selvaraj, Tallapaneni, Vyshnavi, Joghee Nanjan, Chandrasekar Moola, Barge, Sagar, Mohan, Surender, Nanjan, Moola Joghee
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier B.V. 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018918/
https://ncbi.nlm.nih.gov/pubmed/33823185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2021.174082
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak